Who Owns GE HealthCare?
GE HealthCare (NASDAQ: GEHC) is an independent publicly traded American healthcare technology company spun off from General Electric in January 2023. The company is headquartered in Chicago, Illinois, and reported revenue of $5.3 billion in Q2 2026, up 5.7% year-over-year. GE HealthCare acquired Intelerad for approximately $2.3 billion in March 2026. The company has an installed base of over 4 million imaging, mobile, diagnostic, and monitoring devices worldwide and operates in more than 160 countries.
Parent Company
Founded
1994
Status
Publicly Traded
Headquarters
premiumpremiumGlobalall-agesclimate goalscircular economyethical supply chainhealth access expansionmedical device recyclingOfficial Website
Who Owns GE HealthCare?
- Parent Company: GE HealthCare Technologies Inc.
- Ownership Type: Public corporation
- Company Type: Publicly Traded
- Stock Ticker: Nasdaq: GEHC
| Brand | Parent Company | Ownership Type |
|---|---|---|
| GE HealthCare | GE HealthCare Technologies Inc. | Public corporation |
Where to Buy
Disclosure: We may earn commission from purchases
GE HealthCare on AmazonHistory of GE HealthCare
- Founded: 1994
- Founders: General Electric (healthcare division, spun off as independent company in 2023)
GE HealthCare traces its origins to General Electric's healthcare division, which built diagnostic imaging equipment for decades. The division developed expertise in X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound technologies.
In 2021, GE Chairman and CEO H. Lawrence Culp Jr. announced that General Electric would split into three independent public companies: GE HealthCare, GE Aerospace, and GE Vernova. GE HealthCare was the first to separate, completing its spin-off on January 4, 2023. The new company began trading on the NASDAQ under the ticker symbol GEHC.
As an independent company, GE HealthCare expanded through acquisitions. In March 2026, the company acquired Intelerad Medical Systems for approximately $2.293 billion in cash. Intelerad provides medical imaging sharing and workflow solutions, and the acquisition was included in the Advanced Imaging Solutions segment. This acquisition expanded GE HealthCare's radiology workflow capabilities and strengthened its position in imaging informatics.
In Q2 2026, GE HealthCare reported revenue of $5.3 billion, up 5.7% overall and 3.5% organically. Organic orders grew 11.1%, and net income reached $561 million. The company reaffirmed its full-year 2026 guidance, expecting organic revenue growth of 3.0% to 4.0% and adjusted EPS of $4.80 to $5.00.
About GE HealthCare Technologies Inc.
What does GE HealthCare do?
GE HealthCare Technologies Inc. develops, manufactures, and sells medical imaging, diagnostics, and healthcare IT solutions. The company operates through four segments: Imaging (MRI, CT, X-ray), Ultrasound, Patient Care Solutions (patient monitoring, healthcare IT), and Pharmaceutical Diagnostics (contrast agents, radiopharmaceuticals). GE HealthCare serves customers in over 160 countries.
Is GE HealthCare publicly traded?
Yes, GE HealthCare Technologies Inc. is publicly traded on the Nasdaq stock exchange under ticker GEHC. The company was spun off from General Electric on January 4, 2023, and has been independently traded since. General Electric does not retain a significant stake.
Who is the CEO of GE HealthCare?
Peter Arduini serves as President and CEO of GE HealthCare. He was appointed to lead GE's healthcare division in 2022 ahead of the January 2023 spinoff and has continued as CEO of the independent company.
What is GE HealthCare's annual revenue?
GE HealthCare reported revenue of $20.1 billion for fiscal year 2025, up from $19.6 billion in 2024. Net income for 2025 was $2.0 billion. The company's growth was driven by strong demand for medical imaging equipment, AI-enabled imaging solutions, and pharmaceutical diagnostics products.
How was GE HealthCare created?
GE HealthCare was created through the spinoff of General Electric's healthcare division on January 4, 2023. The spinoff was part of GE's broader restructuring, which also created GE Vernova (April 2024) and GE Aerospace as independent companies.
What acquisitions has GE HealthCare made recently?
In 2025, GE HealthCare acquired Impact Medical's NMPA-approved AI software for CT imaging analysis, strengthening its position in the Chinese healthcare AI market. The company has also invested in AI-enabled imaging products and digital health platforms.
Where is GE HealthCare headquartered?
GE HealthCare is headquartered in Chicago, Illinois, USA. The company has manufacturing facilities in the United States, United Kingdom, France, China, and India, and serves customers in over 160 countries.
Who owns GE HealthCare?
GE HealthCare is a publicly traded company with a dispersed shareholder base. Institutional investors hold the majority of shares, with no single controlling shareholder. General Electric does not retain a significant stake following the spinoff.
- Founded: 2023
- Headquarters: Chicago, Illinois, USA
- Company Type: Publicly Traded
- Stock: Nasdaq: GEHC
- Revenue: $20.1 billion (FY2025)
- Employees: approximately 51,000
Where Is GE HealthCare Made / Based?
- Headquarters: Chicago, Illinois, USA
- Manufacturing / Operations: United States, United Kingdom, France, China, India
GE HealthCare Categories & Tags
GE HealthCare Sustainability & Ethics
As a standalone entity, GE HealthCare has established its own sustainability goals focused on expanding global health access and reducing its environmental footprint.
The company has committed to reducing its operational greenhouse gas emissions (Scope 1 and 2) by 50% by 2030, and achieving net-zero emissions across its entire value chain (Scope 3) by 2050.
GE HealthCare's GoldSeal refurbished equipment program extends the life of medical imaging machines, reducing electronic waste and making advanced technology more affordable for developing markets. This circular economy initiative is a core part of the company's sustainability strategy.
The company enforces an Ethical Supply Chain program and Human Rights Statement of Principles, ensuring responsible mineral sourcing and fair labor practices across its global manufacturing network.
In Q2 2026, GE HealthCare continued investing in AI-powered diagnostic tools that can help reduce unnecessary procedures and optimize imaging workflows, contributing to more efficient healthcare delivery.
Awards & Recognition
GE HealthCare has been recognized as a leader in medical technology and corporate practices. In 2025, the company was named to Fortune's World's Most Admired Companies list, highlighting its successful transition to an independent company.
The company frequently wins industry awards for its innovations in AI-powered diagnostic imaging and ultrasound technologies. Frost & Sullivan has recognized GE HealthCare with Best Practices awards for its technology innovations.
The Intelerad acquisition in March 2026 expanded GE HealthCare's imaging informatics capabilities and was noted as a strategic move to strengthen its digital health portfolio.
GE HealthCare Recalls & Controversies
Due to the critical nature of medical equipment, GE HealthCare operates under strict FDA oversight and frequently issues corrective actions:
- Nuclear Medicine Systems Recall (2022-2023): GE HealthCare recalled certain nuclear medicine imaging systems due to a mechanical failure risk that could cause the 1,200-lb detector to fall and potentially crush a patient.
- Anesthesia Delivery Systems (2025): The FDA identified a Class I recall (the most serious type) for certain Carestation Anesthesia Systems due to a risk of ventilation failure, prompting urgent software and hardware corrections.
- Cybersecurity Vulnerabilities (2024): The company recalled legacy cardiology information systems (Muse 5) due to identified cybersecurity risks that could allow unauthorized access to patient data, though the system had been out of regular technical support for over a decade.
These recalls reflect the inherent risks of manufacturing life-critical medical devices and the company's compliance with FDA reporting requirements.
GE HealthCare Ownership: Pros & Cons
Advantages
- +Complete strategic independence allows the company to reinvest profits entirely into healthcare R&D
- +Installed base of over 4 million devices generates consistent, high-margin service and software revenue
- +Market leader in complex medical technologies including MRI, CT, and ultrasound
- +The Intelerad acquisition expands digital health and imaging informatics capabilities
- +Organic orders growth of 11.1% in Q2 2026 indicates continued demand
Considerations
- -Operates in a highly regulated global environment requiring constant compliance with the FDA, EMA, and other international health bodies
- -Faces intense competition from Siemens Healthineers and Philips Healthcare
- -Hospital capital expenditure budgets are sensitive to macroeconomic conditions and healthcare policy changes
- -Patient Care Solutions segment has faced revenue challenges in recent quarters
Frequently Asked Questions About GE HealthCare
Sources & Further Reading
Competitors to GE HealthCare
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Danaher | USA | 1996 | Mass market | Global | All Genders | |
| Good Rx | USA | 2011 | Mass market | Global | All-ages | |
| Zimmer Biomet | USA | 2016 | Premium | Global | All-ages | |
| Siemens | Germany | 2018 | Premium | Global | All-ages | |
| Starz Entertainment | United States | 1994 | Premium | United states | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsCepheid
Owned by Danaher Corporation
Molecular diagnostics company specializing in point-of-care PCR testing systems, owned by Danaher Corporation.
diagnosticsmolecular-testinginfectious-disease
Healthcare PharmaceuticalsGoodRx
Owned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
prescription-savingshealthcare-technologydrug-prices
Healthcare PharmaceuticalsOrthoGrid Systems
Owned by Zimmer Biomet Holdings, Inc.
American medical technology company specializing in AI-powered surgical guidance systems for orthopedic procedures, acquired by Zimmer Biomet.
ai-technologysurgical-guidanceorthopedic
Healthcare PharmaceuticalsSiemens Healthineers
Owned by Siemens AG
German medical technology and healthcare equipment company providing diagnostic imaging and laboratory diagnostics, owned by Siemens AG.
medical-technologyhealthcarediagnostics
Media EntertainmentSTARZ
Owned by STARZ Entertainment Corp.
Premium cable network and streaming service targeting women and underrepresented audiences. Independent publicly traded company since May 2025. Trades on Nasdaq under STRZ.
premium-cablestreaming-serviceoriginal-series
Competitive Analysis
Market Positioning: GE HealthCare competes with 5 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Independent Alternatives to GE HealthCare
Looking for brands with different ownership structures? These similar brands are not owned by GE HealthCare Technologies Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsPhilips
Owned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
healthcare-technologyelectronicsmedical-devices
Publicly Traded
Philips operates independently without a large parent corporation.
Healthcare PharmaceuticalsPfizer
Owned by Pfizer Inc.
American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.
pharmaceuticalvaccinesmedicines
Publicly Traded
Pfizer operates independently without a large parent corporation.
Healthcare PharmaceuticalsTirosint
Owned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
levothyroxinehypothyroidismthyroid
Privately Owned
Tirosint is privately owned, unlike GE HealthCare which is under a publicly traded parent company.
Healthcare PharmaceuticalsAlcon
Owned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
eye-carecontact-lensesophthalmic
Publicly Traded
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsGoodRx
Owned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
prescription-savingshealthcare-technologydrug-prices
Publicly Traded
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsHerbalife
Owned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
nutritiondietary-supplementsweight-management
Publicly Traded
Herbalife operates independently without a large parent corporation.
GE HealthCare Technologies Inc. Stock Information
Jobs at GE HealthCare Technologies Inc.
Latest News About GE HealthCare
Related Articles About GE HealthCare
View more articles
Entertainment
Toy Brand Ownership: From LEGO to Hasbro
LEGO is family-owned by the Kirk Kristiansens. Hasbro and Mattel are Wall Street-owned. Bandai Namco owns Tamagotchi. Discover who owns the biggest toy brands and why it matters. Explore our database.
Who Brands StaffSep 4, 2026
ToysLegoHasbro
Pop Culture
Video Game Brands and Their Corporate Parents
EA sold for $55B to Saudi Arabia's PIF, Silver Lake and Kushner's Affinity. Microsoft bought Activision Blizzard for $75.4B. Tencent owns Riot, Supercell, and stakes in Epic. Sony bought Bungie for $3.6B. Discover video game brands and their corporate parents.
Who Brands StaffSep 3, 2026
Video GamesAcquisitionsEa
Pop Culture
Brands That Appeared in Super Bowl Ads Then Got Acquired
Poppi ran a Super Bowl ad in February 2025 and PepsiCo bought it for $1.95B. Grubhub debuted in Super Bowl LX after Wonder acquired it for $650M. WeatherTech ran its 14th ad. Discover brands that appeared in Super Bowl ads then got acquired.
Who Brands StaffSep 2, 2026
Super BowlAcquisitionsPoppi
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription
Brandpharmaceutical
Activase
Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.
Brand in Healthcare & Pharmaceuticals
thrombolyticstroke-treatment